Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1264 studies found for:    Open Studies | "Leukemia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leukemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Condition: Leukemia
Interventions: Drug: ATRA;   Drug: ATO;   Drug: GO (Gemtuzumab ozogamicin);   Drug: Methylprednisolone
2 Not yet recruiting Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
Condition: Acute Promyelocytic Leukemia
Intervention: Other: QoL questionnaires
3 Recruiting Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: Realgar-Indigo naturalis formula;   Drug: all-trans retinoic acid;   Drug: Arsenic trioxide;   Drug: Hydroxyurea
4 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia
Condition: Leukemia
Intervention: Biological: CD19-targeted CAR-T cells
5 Recruiting A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Interventions: Drug: Ibrutinib;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Rituximab
6 Recruiting Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Intervention: Drug: Ara-c
7 Recruiting Proteasome Inhibition in Acute Promyelocytic Leukemia
Condition: Relapsed Acute Promyelocytic Leukemia
Intervention: Drug: Bortezomib
8 Recruiting Samples From Leukemia Patients and Their Donors to Identify Specific Antigens
Condition: Leukemia
Intervention:
9 Recruiting Alternative Splicing and Leukemia Initiating Cells
Condition: Acute Myeloid Leukemia
Intervention: Other: Assessment of splicing variants
10 Recruiting Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: Arsenic trioxide;   Drug: Idarubicin;   Drug: Cytarabine;   Drug: Tretinoin;   Drug: Mitoxantrone;   Drug: Mercaptopurine;   Drug: Methotrexate
11 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
12 Recruiting B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Condition: Chronic Lymphocytic Leukemia
Intervention:
13 Recruiting Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: ATRA + IDA
14 Recruiting French Registry of First-line Treatment of Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Intervention:
15 Recruiting A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib
16 Recruiting 2CDA With Rituximab in Hairy Cell Leukemia
Condition: Leukemia
Interventions: Drug: Cladribine;   Drug: Rituximab
17 Not yet recruiting A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Other: Standard Leukemia Care;   Other: Palliative Care
18 Recruiting Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia
Condition: Leukemia
Interventions: Drug: Fludarabine;   Drug: Clofarabine;   Drug: Busulfan;   Drug: SAHA;   Procedure: Stem Cell Infusion (SCT);   Drug: Thymoglobulin
19 Recruiting Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia
Interventions: Drug: Busulfan;   Drug: Clofarabine;   Drug: Gemcitabine;   Drug: Thymoglobulin;   Procedure: Allogeneic Stem Cell Transplantation;   Drug: Filgrastim;   Drug: Tacrolimus;   Drug: Methotrexate
20 Recruiting Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Intervention: Drug: Cladribine s.c. injection, HCL treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.